
Chris Sale’s three‑year stretch with the Atlanta Braves from 2024 through 2026 has been extraordinary for a pitcher in his mid‑30s. Over at least 400 innings, he posted a 2.36 ERA and a 2.31 FIP, both the best among qualified starters, while striking out 31.7% of batters and posting a 26.2% strikeout‑minus‑walk rate, the top two metrics in the Modern Era for pitchers age 35 or older.
His ERA+ stayed above 160 each season, ranking him among a tiny group that includes Lefty Grove, Randy Johnson, and Justin Verlander, and he joins Randy Johnson as the only pitchers to log three consecutive seasons with a 160+ ERA+ at that age. Sale’s 178 cumulative ERA+ for the period tops all MLB pitchers, second only to Jacob deGrom’s 188 over any three‑year span in the past decade, and his +88 pitching run value placed him third in that metric.
Only one other Braves starter, Greg Maddux, has recorded a 160+ ERA+ in three straight seasons, doing so from 1993‑98, underscoring how rare Sale’s achievement is. Despite a history of injuries that limited him to 151 innings between 2020‑23, the veteran left‑hander has proved that his upside outweighs the risk, delivering elite performance well into his late 30s.
MLB · 5h ago
MLB · 1d ago
MLB · 2d ago
See all videos